NYU Langone Health - Long Island — Mineola, New York

NYU Langone Health - Long Island is a clinical research site located in Mineola, New York, United States 11501.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

NYU Langone Health - Long Island has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Hereditary Angioedema, Ovarian Neoplasms, Endometrial Neoplasms.

Sponsors: Intellia Therapeutics, Eli Lilly and Company, Medstar Health Research Institute.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Health - Long Island?

NYU Langone Health - Long Island has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Health - Long Island conducted?

NYU Langone Health - Long Island has 3 clinical trials on record, with 3 currently active. Their work covers Hereditary Angioedema, Ovarian Neoplasms, Endometrial Neoplasms.

Is NYU Langone Health - Long Island accredited by Crixeo Health?

NYU Langone Health - Long Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Health - Long Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.